SEC Tracker
Get the app

Aspen Neuroscience ASPE

Andrew Spaventa (Director) converted 250,415 ASPE

Form
4
Filed
Importance
Routine
  1. 70,194 common shares acquired
  2. 180,221 common shares acquired
  3. Shares held by Axon Holdings, LLC Series XIII - Aspen Seed
  4. Shares held by The Andrew K. Spaventa Living Trust Dated April 9, 2014

Written from the Form 4 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Aspen Neuroscience files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float not reported.

  1. Acura Pharmaceuticals ACUR
  2. Ayala Pharmaceuticals ADXS
  3. Ampio Pharmaceuticals AMPE
  4. Alterity Therapeutics ATHE
  5. Adhera Therapeutics ATRX